This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Approval for the architect ausab reagent kit, which is indicated for: architect ausab reagent kit: the architect ausab assay is a chemiluminescent microparticle immunoassay (cmia) for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) in human adult and pediatric serum and plasma (dipotassium edta, lithium heparin, and sodium heparin) and neonatal serum. It is intended for quantitative measurement of antibody response following hepatitis b virus (hbv) vaccination, determination of hbv immune status, and for the laboratory diagnosis of hbv disease associated with hbv infection when used in conjunction with other laboratory results and clinical information. Architect ausab calibrators: the architect ausab calibrators are used to calibrate the architect i system when the system is used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab calibrators has not been established with any other anti-hbs assays. Architect ausab controls: the architect ausab controls are used for monitoring the performance of the architect i system when used for the quantitative determination of antibody to hepatitis b surface antigen (anti-hbs) using the architect ausab reagent kit. The performance of the architect ausab controls has not been established with any other anti-hbs assays.
| Device | ABBOTT ARCHITECT AUSAB |
| Classification Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
| Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
| Applicant | ABBOTT LABORATORIES INC |
| Date Received | 2005-12-09 |
| Decision Date | 2006-06-01 |
| Notice Date | 2006-08-17 |
| PMA | P050051 |
| Supplement | S |
| Product Code | LOM |
| Docket Number | 06M-0321 |
| Advisory Committee | Microbiology |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | ABBOTT LABORATORIES INC 100 Abbott Park Road dept 9va- Ap8-1 abbott Park, IL 60064 |
| Summary: | Summary of Safety and Effectiveness |
| Labeling: | Labeling |
| Approval Order: | Approval Order |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P050051 | Original Filing | |
| S049 | 2023-01-06 | 30-day Notice |
| S048 | 2022-11-07 | 30-day Notice |
| S047 | 2022-09-14 | 30-day Notice |
| S046 | 2022-09-09 | 30-day Notice |
| S045 | 2021-11-18 | 30-day Notice |
| S044 | 2021-11-09 | 30-day Notice |
| S043 | ||
| S042 | 2021-08-11 | 30-day Notice |
| S041 | 2021-02-09 | Real-time Process |
| S040 | 2020-10-16 | 30-day Notice |
| S039 | 2020-03-16 | Normal 180 Day Track No User Fee |
| S038 | 2020-03-16 | Normal 180 Day Track No User Fee |
| S037 | ||
| S036 | 2019-11-04 | 30-day Notice |
| S035 | 2019-06-10 | 30-day Notice |
| S034 | 2018-10-16 | 30-day Notice |
| S033 | 2017-12-21 | Normal 180 Day Track |
| S032 | 2016-08-22 | Normal 180 Day Track |
| S031 | 2016-06-14 | 30-day Notice |
| S030 | 2015-07-16 | 30-day Notice |
| S029 | 2014-12-04 | 30-day Notice |
| S028 | 2014-11-13 | 30-day Notice |
| S027 | 2014-10-03 | 30-day Notice |
| S026 | 2014-03-18 | 30-day Notice |
| S025 | 2013-12-20 | 30-day Notice |
| S024 | 2013-10-30 | 30-day Notice |
| S023 | 2013-10-28 | 30-day Notice |
| S022 | 2013-09-24 | 30-day Notice |
| S021 | 2013-06-21 | 30-day Notice |
| S020 | 2013-02-11 | 30-day Notice |
| S019 | 2012-11-19 | 30-day Notice |
| S018 | 2012-11-15 | 30-day Notice |
| S017 | 2012-11-13 | 30-day Notice |
| S016 | 2012-11-01 | 30-day Notice |
| S015 | 2012-08-03 | 30-day Notice |
| S014 | 2011-11-23 | Special (immediate Track) |
| S013 | 2011-05-25 | 30-day Notice |
| S012 | 2011-05-04 | Normal 180 Day Track No User Fee |
| S011 | 2011-04-18 | 30-day Notice |
| S010 | 2011-02-25 | 30-day Notice |
| S009 | 2011-02-17 | Normal 180 Day Track No User Fee |
| S008 | 2010-12-22 | Special (immediate Track) |
| S007 | 2010-11-22 | Normal 180 Day Track No User Fee |
| S006 | 2010-11-01 | Normal 180 Day Track No User Fee |
| S005 | 2010-08-23 | Normal 180 Day Track No User Fee |
| S004 | 2009-02-12 | Normal 180 Day Track |
| S003 | 2008-09-29 | Real-time Process |
| S002 | 2007-10-19 | Real-time Process |
| S001 | 2006-06-15 | 135 Review Track For 30-day Notice |